Developer docs
API playgroundTry for free, no card

Search company profiles

FathomX

Full company profile

uuid0002lpv

Namestring
FathomX
Websiteurl
fathomx.co
Company typeenum
Private
Founded yearint
2019
Short descriptiontext

FathomX is a Singapore-based medical imaging AI spin-off from the National University of Singapore, founded in 2019, that develops AI-powered technology to assist healthcare providers in breast cancer detection and diagnosis.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSingapore, Singapore
HQ citystring
Singapore
HQ countrystring
Singapore
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
medical imaging AI, breast cancer detection, diagnostic radiology AI, AI mammography analysis, healthcare AI software
Industry3 codes
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAHABAF
Mammography & Breast Imaging Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
Product category
Medical Imaging AI
Social media profiles1 record
Cost components2 values
Personnel, Technology or R&D
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

FathomX is an AI medical imaging company that develops artificial-intelligence-based software for breast cancer detection and diagnosis. As a spin-off from the National University of Singapore, the company applies AI to breast imaging analysis to help healthcare providers improve diagnostic accuracy and efficiency in mammography and related workflows.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1AI Breast Cancer Detection Software
CategoryMedical Imaging AI
Description

AI-powered software for breast cancer detection and diagnosis from medical imaging, intended for healthcare providers performing breast cancer screening and diagnosis.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Peers10 records
1Zebra Medical Vision (Nanox AI)
TypeEmerging player
Description

Zebra Medical Vision, now part of Nanox, is a broad medical imaging AI vendor whose multi-modality strategy partially overlaps with FathomX's diagnostic AI positioning as an emerging peer.

TypeDirect peer
Description

Volpara is a publicly-listed breast imaging analytics company offering AI-driven mammography reporting, density assessment, and cancer risk prediction. It directly competes with FathomX in breast cancer AI for screening workflows.

TypeDirect peer
Description

iCAD develops AI-based computer-aided detection and breast density solutions for mammography, directly overlapping with FathomX's breast cancer detection and diagnosis use case.

TypeDirect peer
Description

Therapixel is a French company specializing in AI-powered mammography reading (MammoScreen), making it a direct peer to FathomX in breast imaging AI diagnostics.

TypeDirect peer
Description

Lunit is a Korean medical AI company whose Lunit INSIGHT MMG product targets mammography AI, directly competing with FathomX in the same clinical workflow with regional APAC overlap.

TypeBroad incumbent
Description

Hologic is a major mammography equipment vendor (3D Dimensions) with an integrated AI portfolio (Genius AI). It competes with FathomX as an incumbent that bundles imaging AI into its hardware sales.

TypeBroad incumbent
Description

DeepHealth, a RadNet company, offers AI-driven mammography triage and diagnostic solutions (Saige-Dx). It is a broad incumbent providing integrated breast imaging AI in large-scale screening networks.

TypeBroad incumbent
Description

Google Health has published and deployed AI models for mammography screening in research and partnership settings, representing a well-resourced broad incumbent in the breast imaging AI category.

TypeEmerging player
Description

Qure.ai is an emerging medical imaging AI vendor with FDA-cleared chest and head CT products that is expanding into adjacent imaging AI use cases, partially overlapping with FathomX's diagnostic AI positioning.

TypeEmerging player
Description

DeepTek is an India-based medical imaging AI company with deployments in APAC, representing a regional emerging peer with overlapping AI imaging technology but broader modality coverage.

Market position
Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

FathomX

Medical Imaging AIfathomx.co

FathomX is a Singapore-based medical imaging AI spin-off from the National University of Singapore, founded in 2019, that develops AI-powered technology to assist healthcare providers in breast cancer detection and diagnosis.

FathomX firmographics

Firmographics
Name
FathomX
Website
https://fathomx.co
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
FathomX is a Singapore-based medical imaging AI spin-off from the National University of Singapore, founded in 2019, that develops AI-powered technology to assist healthcare providers in breast cancer detection and diagnosis.
Ownership category
akta.pro rank

FathomX industry classification

Industry
Product category
Medical Imaging AI
akta.pro industry
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAHABAF
Mammography & Breast Imaging Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • Medical imaging AI
  • Breast cancer detection
  • Diagnostic radiology AI
  • AI mammography analysis
  • Healthcare AI software

Where FathomX is headquartered

Location

Headquarters

HQ city
Singapore
HQ country
Singapore
HQ region
Asia

Markets served

FathomX business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D

FathomX product offering

Product offering

Core offering

FathomX is an AI medical imaging company that develops artificial-intelligence-based software for breast cancer detection and diagnosis. As a spin-off from the National University of Singapore, the company applies AI to breast imaging analysis to help healthcare providers improve diagnostic accuracy and efficiency in mammography and related workflows.

Differentiator

Problem solved

Functional benefit

Products and services

  • AI Breast Cancer Detection Software AI-powered software for breast cancer detection and diagnosis from medical imaging, intended for healthcare providers performing breast cancer screening and diagnosis.

Companies that use FathomX

Customer profile

Segments1 record

Ideal customer profiles1 record

FathomX technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

FathomX partnerships and signals

Strategic signal

Scale indicators1 record

FathomX competitors and assessment

Company assessment

Emerging players

  • Zebra Medical Vision (Nanox AI): Zebra Medical Vision, now part of Nanox, is a broad medical imaging AI vendor whose multi-modality strategy partially overlaps with FathomX's diagnostic AI positioning as an emerging peer.
  • Qure.ai: Qure.ai is an emerging medical imaging AI vendor with FDA-cleared chest and head CT products that is expanding into adjacent imaging AI use cases, partially overlapping with FathomX's diagnostic AI positioning.
  • DeepTek.ai: DeepTek is an India-based medical imaging AI company with deployments in APAC, representing a regional emerging peer with overlapping AI imaging technology but broader modality coverage.

Direct peers

  • Volpara Health Technologies: Volpara is a publicly-listed breast imaging analytics company offering AI-driven mammography reporting, density assessment, and cancer risk prediction. It directly competes with FathomX in breast cancer AI for screening workflows.
  • iCAD, Inc. iCAD develops AI-based computer-aided detection and breast density solutions for mammography, directly overlapping with FathomX's breast cancer detection and diagnosis use case.
  • Therapixel: Therapixel is a French company specializing in AI-powered mammography reading (MammoScreen), making it a direct peer to FathomX in breast imaging AI diagnostics.
  • Lunit: Lunit is a Korean medical AI company whose Lunit INSIGHT MMG product targets mammography AI, directly competing with FathomX in the same clinical workflow with regional APAC overlap.

Broad incumbents

  • Hologic, Inc. Hologic is a major mammography equipment vendor (3D Dimensions) with an integrated AI portfolio (Genius AI). It competes with FathomX as an incumbent that bundles imaging AI into its hardware sales.
  • DeepHealth (RadNet subsidiary): DeepHealth, a RadNet company, offers AI-driven mammography triage and diagnostic solutions (Saige-Dx). It is a broad incumbent providing integrated breast imaging AI in large-scale screening networks.
  • Google Health (breast cancer AI): Google Health has published and deployed AI models for mammography screening in research and partnership settings, representing a well-resourced broad incumbent in the breast imaging AI category.

Market position

Customer concentration

FathomX social profiles

Digital presence

FathomX financial estimates

Financial estimate

Revenue estimate

Valuation estimate

FathomX leadership team

Management profile

Number of profiles

Profiles6 records

FathomX funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

FathomX M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FathomX

What does FathomX do?

FathomX is an AI medical imaging company that develops artificial-intelligence-based software for breast cancer detection and diagnosis. As a spin-off from the National University of Singapore, the company applies AI to breast imaging analysis to help healthcare providers improve diagnostic accuracy and efficiency in mammography and related workflows.

Is FathomX a public or private company?

FathomX is a private company. It is classified as venture growth investor backed and is currently operating.

When was FathomX founded?

FathomX was founded in 2019. It employs 1 to 10 people.

Where is FathomX based?

FathomX is headquartered in Singapore, Singapore, in the Asia region.

Who are FathomX's main competitors?

Emerging players on record are Zebra Medical Vision (Nanox AI), Qure.ai and DeepTek.ai. Direct peers are Volpara Health Technologies, iCAD, Inc., Therapixel and Lunit. Broad incumbents are Hologic, Inc., DeepHealth (RadNet subsidiary) and Google Health (breast cancer AI).

Does FathomX have an API?

No public API is recorded for FathomX.

What industry is FathomX in?

FathomX's product category is Medical Imaging AI. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales